The Importance of AI in Health Care

Kevin Lilly, a healthcare technology professional, holds a master of business administration degree in international management from the American Graduate School of International Management. A healthcare technology enthusiast, Kevin Lilly believes in integrating artificial intelligence (AI) in health care.

Data collection and management are critical facets in healthcare provision especially for data-informed human decisions. The myriad of organized and raw medical data collected from medical histories, records, Internet-enabled devices, manual input, and medical electronics significantly complicates manual analysis and problem-solving.

AI in health care consolidates the data and allows for real-time access and analysis for patterns, root causes, and feasible remedies. Equally important, real-time medical history updates enable medical attendants to adapt patient handling regimens based on the situation thus reducing contraindications. This feature would otherwise be time- and resource-intensive using manual analysis and limited analysis tools. AI in healthcare data management ensures faster, more accurate, and positive patient outcomes.

Agreement with Premier’s SURPASS

A health care technology executive, Kevin Lilly provided biotechnology, medical device, and software solutions as senior vice president of sales at MiMedx Group, Inc. In this position, Kevin Lilly assisted MiMedx in expanding operations in US and global human cells, tissues, and cellular or tissue-based products markets.

A leading company in the placental biologics sector, MiMedx creates regenerative medicine using birth tissue as a platform. In March 2021, the company was awarded a Group Purchasing Agreement for the Synergizing for Unparalleled Results in Procurement and Strategic Sourcing (SURPASS) purchasing program by Premier, Inc. The Regenerative Skin Grafting Products agreement stipulates SURPASS members can choose to receive special terms and pricing for MiMedx's advanced wound care product utilizing placental-based tissue.

The agreement aids MiMedx in furnishing health care solutions at a reduced cost and enhances its place in the advanced wound care market. A health care improvement company, Premier works with more than 200,000 providers and 4,100 US hospitals.

Exercises to Improve Your Lacrosse Game

Kevin Lilly holds an MBA in international management from the Thunderbird School of Global Management in Phoenix, Arizona. He also earned BS degrees in management and marketing from Kansas State University. Kevin Lilly has over 30 years of experience in healthcare sales, marketing, and general management. Outside his professional career, he mentors people under 35 on life skills and also coaches Trojan Youth Lacrosse.

Good fitness is required for playing lacrosse. For example, lacrosse requires a lot of sprinting across the game field. Here are a few exercises to ensure sufficient fitness to play the game.

1. Long runs are for building endurance to sustain a 60 minute lacrosse game. A minimum of two long runs a week are recommended, along with incorporation of hill sprinting and interval running to complement this training regimen.

2. Planks will help develop core strength. Core strength is necessary for sufficient power to shoot the ball and for playing defense. You should work toward a minimum of 10 planks for at least two minutes per plank.

3. Squats also contribute to developing core and leg muscle strength. Adding squats to this plan will contribute to increased movement speed and muscle strength.

4. Push-ups will develop chest and arm muscle strength. This will help in defending a position on the field from opponents. Five sets of 20 push-ups are recommended.

MDX Uses Birth Tissue to Treatment

Kevin Lilly is the vice president of commercial operations at Carolina Precision Technologies. Before taking up this role, Kevin Lilly worked as a senior vice president of sales at the publicly traded company MiMedx Group (MDXG) from 2015 to 2019.

MiMedx is a biopharmaceutical company that was founded in 2008. The organization has its headquarters in Marietta, Georgia, and is seen as an industry leader in therapeutic biologics and advanced wound care. MDXG uses birth tissue, such as the placenta, umbilical cord, and amniotic sac, to create skin that can then be used to treat burn injury, diabetic foot ulcers, and other similar conditions. Birth tissue has flexible properties that allow it to conform and provide a protective cover around a wound region. This natural covering aids in tissue remodeling and restoration which then leads to faster recovery.

MiMedx acquires birth tissue donations from new mothers who delivered through Cesarean section. Using these donations, MDXG continues to advance medical research and find new ways to treat medical conditions.

MiMedx Group Expands Placental Biologics

Kevin Lilly is an established leader in the healthcare technology sphere who guided sales with the MiMedx Group for four years as senior vice president. The regenerative medicine enterprise Kevin Lilly helped expand maintains a leading industry presence with patent-protected processes that place placental tissue allografts in diverse healthcare sectors.

In March 2021, MiMedx announced that it had entered into a significant group purchasing agreement with Premier Inc. spanning its amniotic tissue portfolio. Administered through the SURPASS (Synergizing for Unparalleled Results in Procurement and Strategic Sourcing) program, the agreement will provide an array of regenerative skin-grafting products to SURPASS members at special terms and pricing.

As the CEO of MiMedx described it, this places MiMedx at the forefront when it comes to providing advanced wound care patients with access to PURION processed tissue technologies. At the same time, the agreement will make placental biologics more affordable to a wider range of patients living with hard-to-heal and chronic wounds.

 

What You Should Know about the EpiCord

Kevin Lilly is an accomplished business leader in the medical products industry. A longtime resident of the greater Atlanta area, Kevin Lilly most recently served as senior vice president of sales with MiMedx in Marietta, Georgia. One of MiMedx’s signature products is the EpiCord.

As an allograft product, EpiCord employs donated human tissue to support the healing process in flesh wounds. Specifically comprised of human umbilical cord, this thick tissue graft covers wounds to establish a protected healing environment,

EpiCord grafts are highly expandable, allow for easy suturing, conform to uneven surfaces, and promote healing in even significantly deep wounds. Their extracellular matrix of collagen and hyaluronic acid enables the retention of more than 250 regulatory proteins.

The EpiCord is terminally sterilized to ensure absolute cleanliness, and stores for 5 years at room temperature. Extremely easy to apply, this product is applicable for both negative pressure wound therapy and hyperbaric oxygen therapy.

Fortune Ranks MiMedx Fifth among 100

An accomplished sales executive, Kevin Lilly formerly served as the senior vice president of sales at MiMedx, a Georgia-based biopharmaceutical firm that devises treatment solutions for advanced wound care. Through endeavors rooted in cross-functionality and talent development, Kevin Lilly built up and led a sales team that increased sales and helped to propel the company’s growth. Subsequently, MiMedx earned a place on Fortune Magazine’s 2017 list of the 100 Fastest-Growing Companies.

Fortune’s list of the Fastest-Growing Companies recognizes domestic and foreign companies that outperform others in revenue and earnings per share (EPS) growth rates and increased annualized total returns over the course of a three-year period. The magazine’s ranking process evaluates only those companies that meet or exceed specific benchmarks in these areas, in addition to fulfilling a series of preliminary qualifications. The criteria include participation in a major US Stock Exchange, continuous trading activity, and minimum figures for revenue, net income, stock price, and market capitalization.

For its 2017 list of the Fastest-Growing Companies, Fortune restricted consideration to enterprises that posted EPS and revenue annualized growth rates of 15 percent or higher over the course of a three-year timeframe that ended on April 30, 2017. Moreover, it set revenue and net income thresholds at no less than $50 million and $10 million, respectively, for the four quarters that concluded on or prior to that date.

MiMedx secured the fifth spot on the top 100 list with a three-year annualized total return rate of 28 percent. Additionally, it ranked seventh for three-year annual growth rate (AGR) in revenue and 10th for three-year AGR in EPS with 58 percent and 88 percent, respectively. In a statement at the time, the company’s CEO and chairman described the achievement as a tribute to its employees’ work and its products’ healing capabilities.

The Marietta Greek Festival Returns in May 2021

Marketing and management executive Kevin Lilly has decades of experience in transforming health care corporations into more profitable and efficient businesses. While serving as senior vice president of sales at biopharmaceutical Mimedx, he increased sales revenues and optimized the customer experience. Active in his local community, Kevin Lilly volunteers at the Holy Transfiguration Greek Orthodox Church in Marietta, Georgia. He belongs to the church’s fundraising committee and has served as master of ceremonies at the Marietta Greek Festival.

The Marietta Greek Festival is a three-day event that celebrates Greek traditions and culture. It features many musical bands, different Greek dances and traditional Greek dishes such as keftedes and dolmades. In addition, scheduled, 30-minute tours of the Holy Transfiguration Greek Orthodox Church are available for visitors interested in learning more about the church’s Byzantine style, icons, and vestments. The next event is scheduled to take place in May 2021, on the weekend following Mother’s Day. 

Awarix Solutions Improve Patient Experience

Kevin Lilly spent over two decades working in the field of healthcare management. After earning his MBA from Thunderbird School of Global Management, he went on to land senior positions in healthcare corporations including Mimedx and McKesson Technology Solutions. During his time at McKesson, Kevin Lilly served as vice president of sales, where he was responsible for IT software sales worth over $40 million. To boost capacity management and patient visibility, he also led the integration of Awarix solutions at McKesson.

Awarix offers a health care technology system that improves the patient experience while also making it more efficient. Its solutions optimize patient care visibility by posting status reports on electronic boards found in patient rooms as well as desks and corridors. This enables physicians and nurses to access patient information quickly, therefore speeding up the medical response to the latest updates in patient files. Information display is color coded to facilitate the process, highlighting patient status and pending lab or medical orders.